PC
ALXN
PointState Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-95,935
| Closed | -$14.7M | – | 147 |
|
2021
Q1 | $14.7M | Sell |
95,935
-37,186
| -28% | -$5.69M | 0.29% | 52 |
|
2020
Q4 | $20.8M | Buy |
133,121
+98,121
| +280% | +$15.3M | 0.39% | 45 |
|
2020
Q3 | $4.01M | Sell |
35,000
-116,417
| -77% | -$13.3M | 0.11% | 62 |
|
2020
Q2 | $17M | Buy |
151,417
+133,917
| +765% | +$15M | 0.51% | 35 |
|
2020
Q1 | $1.57M | Sell |
17,500
-211,910
| -92% | -$19M | 0.08% | 43 |
|
2019
Q4 | $24.8M | Buy |
+229,410
| New | +$24.8M | 0.45% | 41 |
|
2019
Q2 | – | Sell |
-4,000
| Closed | -$539K | – | 146 |
|
2019
Q1 | $539K | Buy |
+4,000
| New | +$539K | 0.01% | 102 |
|
2018
Q3 | – | Sell |
-707,800
| Closed | -$87.9M | – | 184 |
|
2018
Q2 | $87.9M | Buy |
707,800
+275,400
| +64% | +$34.2M | 0.99% | 27 |
|
2018
Q1 | $48.2M | Buy |
+432,400
| New | +$48.2M | 0.52% | 51 |
|
2017
Q2 | – | Sell |
-79,700
| Closed | -$9.66M | – | 168 |
|
2017
Q1 | $9.66M | Sell |
79,700
-1,029,250
| -93% | -$125M | 0.1% | 95 |
|
2016
Q4 | $136M | Buy |
1,108,950
+915,250
| +473% | +$112M | 1.95% | 12 |
|
2016
Q3 | $23.7M | Buy |
+193,700
| New | +$23.7M | 0.25% | 67 |
|
2015
Q2 | – | Sell |
-110,000
| Closed | -$19.1M | – | 171 |
|
2015
Q1 | $19.1M | Buy |
+110,000
| New | +$19.1M | 0.26% | 64 |
|